Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Chang, Anne B ^a   Lasserson, Toby J ^b   Gaffney, Justin ^a   Connor, Frances L ^a   Garske, Luke A ^c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Adult; Child; Chronic disease; Cough complications; *therapy ; Gastroesophageal reflux complications; *therapy ; Humans; Randomized controlled trials as topic

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADULT DISEASE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; COUGHING; GASTROESOPHAGEAL REFLUX; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; REVIEW; SCORING SYSTEM; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW;

EID: 77950138450     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004823.pub3     Document Type: Review

References (107)

1. Chao 2007 {published and unpublished data} Chao HC, Vandenplas Y. Comparison of the effect of a cornstarch thickened formula and strengthened regular formula on regurgitation, gastric emptying and weight gain in infantile regurgitation. Diseases of the Esophagus 2007;20:155-60.
2. Dordal 1994 {published data only} Dordal MT, Baltazar MA, Roca I, Marques L, Server MT, Botoy J. Nocturnal spasmodic cough in the infant. Evolution after antireflux treatment [Toux spasmodique nocturne chez l'enfant. Evolution après traitement antireflux]. Allergergie et Immunology 1994;26(2):53-8.
3. Eherer 2003 {published and unpublished data} Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scandinavian Journal of Gastroenterology 2003;38(5):462-7.
4. El Serag 2001 {published data only (unpublished sought but not used)} El Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. American Journal of Gastroenterology 2001;96(4):979-83.
5. Havas 1999 {published data only (unpublished sought but not used)} Havas T, Huang S, Levy M, Abi-Hanna D, Truskett P, Priestly J, et al.Posterior pharyngolaryngitis: Double-blind randomised placebo-controlled trial of proton pump inhibitor therapy. Australian Journal of Oto-Laryngology 1999;3(3):243-6.
6. Ing 1997 {published and unpublished data} Ing A. Chronic cough. Respirology 1997;2(4):309-16.
7. Jaspersen 1999 {published data only} Jaspersen D, Diehl KL, Geyer P, Martens E. Omeprazole in reflux-associated chronic persistent cough [Omeprazol - (Antra MUPS) bei refluxassoziiertem chronisch-persistierenden Husten]. Endoskopie Heute 1999;12(2):12-4.
8. Kiljander 2000 {published and unpublished data} Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. European Respiratory Journal 2000;16(4):633-8.
9. Kopec 2001 {published and unpublished data} Kopec SE, Irwin RS, French CL, Wilson MM, Bol S. A double-blind randomized placebo-controlled trial comparing diet and/or cisapride. American Journal of Respiratory & Critical Care Medicine 2001;163(5 Suppl):A64.
10. Moukarzel 2007 {published data only} Moukarzel AA, Abdelnour H, Akatcherian C. Effects of a prethickened formula on esophageal pH and gastric emptying of infants with GER. Journal of Clinical Gastroenterology 2007;41:823-9.
11. Noordzij 2001 {published data only (unpublished sought but not used)} Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, et al.Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111(12):2147-51.
12. Orenstein 1992 {published data only} Orenstein SR, Shalaby TM, Putnam PE. Thickened feedings as a cause of increased coughing when used as therapy for gastroesophageal reflux in infants. Journal of Pediatrics 1992;121(6):913-5.
13. Ours 1999 {published data only (unpublished sought but not used)} Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. American Journal of Gastroenterology 1999;94(11):3131-8.
14. Pawar 2007 {published data only (unpublished sought but not used)} * Pawar S, Lim HJ, Gill M, Smith TL, Merati A, Toohill RJ, Loehrl TA. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study. American Journal of Rhinology 2007;21:695-701.
15. Steward 2004 {published data only (unpublished sought but not used)} Steward DL, Wilson KM, Kelly DH, Patil MS, Schwartzbauer HR, Long JD, Welge JA. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngology- Head & Neck Surgery 2004;131(4):342-50.
16. Vaezi 2006 {published and unpublished data} * Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, et al.Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006;116(2):254-60.
17. Vanderhoof 2003 {published data only (unpublished sought but not used)} Vanderhoof JA, Moran JR, Harris CL, Merkel KL, Orenstein SR. Efficacy of a pre-thickened infant formula: a multicenter, double-blind, randomized, placebo-controlled parallel group trial in 104 infants with symptomatic gastroesophageal reflux. Clinical Pediatrics 2003;42(6):483-95.
18. Wo 2006 {published data only} Wo JM, Koopman J, Harrell SP, Parker K, Winstead W, Lentsch E. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.. American Journal of Gastroenterology 2006;101:1972-8.
19. Ahmad 2004 {published data only} Ahmad I, Batch AJ. Acid reflux management: ENT perspective. Journal of Laryngology & Otology 2004;118(1):25-30.
20. Allen 1998 {published data only} Allen CJ, Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax 1998;53(11):963-8.
21. Allen 2002 {published data only} Allen CJ, Anvari M. Preoperative symptom evaluation and esophageal acid infusion predict response to laparoscopic Nissen fundoplication in gastroesophageal reflux patients who present with cough. Surgical Endoscopy 2002;16(7):1037-41.
22. Allen 2004 {published data only} Allen CJ, Anvari M. Does laparoscopic fundoplication provide long-term control of gastroesophageal reflux related cough?. Surgical Endoscopy 2004;18(4):633-7.
23. Baldi 2006 {published data only} Baldi F, Cappiello R, Cavoli C, Ghersi S, Torresan F, Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World Journal of Gastroenterology 2006;12(1):82-8.
24. Baldi 2006a {published data only} Baldi F, Cavoli C, Ghersi S, Mantovani L, Torresan F, Roda E. Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy. Digestive & Liver Disease 2006;38(7):452-8.
25. Belafsky 2008 {published data only} Belafsky PC, Rees CJ, Rodriguez K, Pryor JS, Katz PO. Esophagopharyngeal reflux. Otolaryngology - Head and Neck Surgery 2008;138:57-61.
26. Brouwer 2003 {published data only} Brouwer R, Kiroff GK. Improvement of respiratory symptoms following laparoscopic Nissen fundoplication. ANZ Journal of Surgery 2003;73(4):189-93.
27. Chandra 2007 {published data only} Chandra KM, Harding SM. Therapy Insight: treatment of gastroesophageal reflux in adults with chronic cough. Nature Clinical Practice Gastroenterology & Hepatology 2007;4:604-13.
28. Chen 2000 {published data only} Chen RY, Thomas RJ. Results of laparoscopic fundoplication where atypical symptoms coexist with oesophageal reflux. ANZ Journal of Surgery 2000;70(12):840-2.
29. Coron 2007 {published data only} Coron E, Hatlebakk JG, Galmiche JP. Medical therapy of gastroesophageal reflux disease. Current Opinion in Gastroenterology 2007;23:434-9.
30. Dalby-Payne 2003 {published data only} Dalby-Payne JR, Morris AM, Craig JC. Meta-analysis of randomized controlled trials on the benefits and risks of using cisapride for the treatment of gastroesophageal reflux in children. Journal of Gastroenterology & Hepatology 2003;18(2):196-202.
31. DeMeester 1990 {published data only} DeMeester TR, Bonavina L, Iascone C, Courtney JV, Skinner DB. Chronic respiratory symptoms and occult gastroesophageal reflux. A prospective clinical study and results of surgical therapy. Annals of Surgery 1990;211(3):337-45.
32. Dore 2007 {published data only} Dore MP, Pedroni A, Pes GM, Maragkoudakis E, Tadeu V, Pirina P, et al.Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease. Digestive Diseases & Sciences 2007; 52(2):463-8.
33. Duffy 2003 {published data only} Duffy JP, Maggard M, Hiyama DT, Atkinson JB, McFadden DW, Ko CY, et al.Laparoscopic Nissen fundoplication improves quality of life in patients with atypical symptoms of gastroesophageal reflux. American Surgeon 2003;69(10):833-8.
34. Ekstrom 2000 {published data only} Ekstrom T, Johansson KE. Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease. Respiratory Medicine 2000;94(12):1166-70.
35. El Hennawi 2004 {published data only} El Hennawi DD, Iskander NM, Ibrahim IH, Serwah AH. Persistent cough: prevalence of gastroesophageal reflux and study of relevant laryngeal signs. Otolaryngology - Head & Neck Surgery 2004;131(5):767-72.
36. Eubanks 2001 {published data only} Eubanks TR, Omelanczuk P, Hillel A, Maronian N, Pope CE, Pellegrini CA. Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy. American Journal of Surgery 2001;181(5):466-70.
37. Farrell 2001 {published data only} Farrell TM, Richardson WS, Trus TL, Smith CD, Hunter JG. Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. British Journal of Surgery 2001;88(12):1649-52.
38. Fock 2008 {published data only} Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, et al.Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update. Journal of Gastroenterology and Hepatology 2008;23:8-22.
39. Fraser 2000 {published data only} Fraser AG, Morton RP, Gillibrand J. Presumed laryngo-pharyngeal reflux: investigate or treat?. Journal of Laryngology & Otology 2000;114(6):441-7.
40. Gatta 2007 {published data only} Gatta L, Vaira D, Sorrenti G, Zucchini S, Sama C, Vakil N. Meta-analysis: The efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2007;25(4): 385-92.
41. Greason 2002 {published data only} Greason KL, Miller DL, Deschamps C, Allen MS, Nichols FC III, Trastek VF, et al.Effects of antireflux procedures on respiratory symptoms. Annals of Thoracic Surgery 2002;73(2):381-5.
42. Grill 1985 {published data only} Grill BB, Hillemeier AC, Semeraro LA, McCallum RW, Gryboski JD. Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastroesophageal reflux. Journal of Pediatrics 1985;106(2):311-6.
43. Habermann 1999 {published data only} Habermann W, Eherer A, Lindbichler F, Raith J, Friedrich G. Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy. Journal of Laryngology & Otology 1999;113(8):734-9.
44. Habermann 2002 {published data only} Habermann W, Kiesler K, Eherer A, Friedrich G. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. Journal of Voice 2002;16(3):425-32.
45. Hui 2000 {published data only} Hui TT, Fass SM, Giurgiu DI, Lida A, Takagi S, Phillips EH. Gastroesophageal disease and nausea: does fundoplication help or hurt?. Archives of Surgery 2000;135(5):545- 9.
46. Hunter 1996 {published data only} Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Annals of Surgery 1996;223(6):673-85.
47. Irwin 1993 {published data only} Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993;104(5):1511-7.
48. Irwin 2002 {published data only} Irwin RS, Zawacki JK, Wilson MM, French CT, Callery MP. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002;121(4):1132-40.
49. Issing 2004 {published data only} Issing WJ, Karkos PD, Perreas K, Folwaczny C, Reichel O. Dual-probe 24-hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux. Journal of Laryngology & Otology 2004;118(11):845-8.
50. Katzka 1996 {published data only} Katzka DA, Paoletti V, Leite L, Castell DO. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. American Journal of Gastroenterology 1996;91(10):2110-3.
51. Leeder 2002 {published data only} Leeder PC, Watson DI, Jamieson GG. Laparoscopic fundoplication for patients with symptoms but no objective evidence of gastroesophageal reflux. Diseases of the Esophagus 2002;15(4):309-14.
52. Monini 2006 {published data only} Monini S, Di Stadio A, Vestri A, Barbara M. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders. Acta Oto-Laryngologica 2006;126(8):866-871.
53. Murray 2006 {published data only} Murry T, Tabaee A, Owczarzak V, Aviv JE. Respiratory retraining therapy and management of laryngopharyngeal reflux in the treatment of patients with cough and paradoxical vocal fold movement disorder. Annals of Otology, Rhinology & Laryngology 2006;115(10):754-8.
54. Novitsky 2002 {published data only} Novitsky YW, Zawacki JK, Irwin RS, French CT, Hussey VM, Callery MP. Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surgical Endoscopy 2002;16(4):567-71.
55. Omari 2006 {published data only} Omari TI, Benninga MA, Sansom L, Butler RN, Dent J, Davidson GP. Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial. Journal of Pediatrics 2006;149(4):468-74.
56. Oridate 2008 {published data only} Oridate N, Takeda H, Asaka M, Nishizawa N, Mesuda Y, Mori M, Furuta Y, Fukuda S. Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients. Digestive Diseases & Sciences 2008;53:2033-8.
57. Poe 2003 {published data only} Poe RH, Kallay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003;123(3):679-84.
58. Songur 2008 {published data only} Songur N, Songur Y, Cerci SS, Ozturk O, Sahin U, Senol A, Yarktas MH. Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease. Nuclear Medicine Communications 2008;29:1066-1072.
59. Swoger 2006 {published data only} Swoger J, Ponsky J, Hicks DM, Richter JE, Abelson TI, Milstein C, et al.Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clinical Gastroenterology & Hepatology 2006;4(4):433-41.
60. Thoman 2002 {published data only} Thoman DS, Hui TT, Spyrou M, Phillips EH. Laparoscopic antireflux surgery and its effect on cough in patients with gastroesophageal reflux disease. Journal of Gastrointestinal Surgery 2002;6(1):17-21.
61. Tibbling 1993 {published data only} Tibbling L. Wrong-way swallowing as a possible cause of bronchitis in patients with gastroesophageal reflux disease. Acta Otolaryngologia 1993;113(3):405-8.
62. Tibbling 1995 {published data only} Tibbling L, Gibellino FM, Johansson KE. Is mis-swallowing or smoking a cause of respiratory symptoms in patients with gastroesophageal reflux disease?. Dysphagia 1995;10(2):113-6.
63. van Zanten 2006 {published data only} Van Zanten SV, Armstrong D, Chiba N, Flook N, White RJ, Chakraborty B, et al.Esomeprazole 40 mg once a day in patients with functional dyspepsia: The randomized, placebo-controlled 'ENTER' trial. American Journal of Gastroenterology 2006;101(9):2096-106.
64. Waring 1995 {published data only} Waring JP, Lacayo L, Hunter J, Katz E, Suwak B. Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease. Diagnosis and response to therapy. Digestive Diseases and Sciences 1995;40(5):1093-7.
65. Wo 1997 {published data only} Wo JM, Grist WJ, Gussack G, Delgaudio JM, Waring JP. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. The American Journal of Gastroenterology 1997;92(12):2160-5.
66. Wright 2003 {published data only} Wright RC, Rhodes KP. Improvement of laryngopharyngeal reflux symptoms after laparoscopic Hill repair. American Journal of Surgery 2003;185(5):455-61.
67. Xinias 2003 {published data only} Xinias I, Spiroglou K, Demertzidou V, Karatza E, Panteliadis C. An anti-regurgitation milk formula in the management of infants with mild to moderate gastroesophageal reflux. Current Therapeutic Research, Clinical & Experimental 2003;64(4):270-8.
68. Yang J 2006 {published data only} Yang JY, Lee HY, Kim NH, Kim YS. The effect of a proton-pump inhibitor in unexplained chronic cough patients. [Korean]. Tuberculosis & Respiratory Diseases 2006;61:137-42.
69. Morice 2008 {published data only} Morice AH, Donaldson JE, Fathi HH. The efficacy of dietary intervention in the treatment of reflux cough [Abstract]. American Thoracic Society International Conference. 2008; A897[#E121].
70. Altman 1998 Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317(7168):1309-12.
71. AMA 1996 American Gastroenterological Associciation. American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology 1996;110(6):1981.
72. Birring 2003 Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58(4):339-43.
73. Britt 2002 Britt H, Miller GC, Knox S, Charles J, Valenti L, Henderson J, et al.Bettering the Evaluation and Care of Health - A Study of General Practice Activity; 2002. Australian Institue of Health and Welfare. Report no.: AIHWCat. No. GEP-10.
74. Chang 1998 Chang AB, Newman RG, Carlin J, Phelan PD, Robertson CF. Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method. European Respiratory Journal 1998;11:462-6.
75. Chang 1999 Chang AB. State of the art: cough, cough receptors, and asthma in children. Pediatric Pulmonology 1999;28:59-70.
76. Chang 2001 Chang AB, Asher MI. A review of cough in children. Journal of Asthma 2001;38(4):299-309.
77. Chang 2003 Chang AB, Phelan PD, Robertson CF, Roberts RDG, Sawyer SM. Relationship between measurements of cough severity. Archives of Disease in Childhood 2003;88:57-60.
78. Chung 1996 Chung KF, Lalloo UG. Diagnosis and management of chronic persistent dry cough. Postgraduate Medicine 1996;72(852): 594-8.
79. Clarke 2003 Clarke M, Oxman AD, editors. Formulating the problem. The Cochrane Reviewers' Handbook 4.2 [updated November 2002]. The Cochrane Collaboration, 2003.
80. Corrao 1996 Corrao WM. Chronic persistent cough: diagnosis and treatment update. Pediatric Annals 1996;25(3):162-8.
81. Daoui 2002 Daoui S, Agostino B, Gallelli L, Emonds X, Rossi F, Advenier C. Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. European Respiratory Journal 2002;20:268-73.
82. Eastburn 2007 Eastburn MM, Katelaris PH, Chang AB. Defining the relationship between gastroesophageal reflux and cough: probabilities, possibilities and limitations. Cough 2007;3:4. [DOI: 10.1186/1745-9974-3-4]
83. Eccles 2002 Eccles R. The powerful placebo in cough studies?. Pulmonary Pharmacology & Therapeutics 2002;15(3):303-8.
84. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F,Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
85. Ferrari 1995 Ferrari M, Olivieri M, Sembenini C, Benini L, Zuccali V, Bardelli E, et al.Tussive effect of capsaicin in patients with gastroesophageal reflux without cough. American Journal of Respiratory & Critical Care Medicine 1995;151:557-61.
86. Field 1999 Field SK, Sutherland LR. Gastroesophageal reflux and asthma: are they related?. Journal of Asthma 1999;36(8):631-44.
87. French 2002 French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest 2002;121(4):1123-31.
88. Gregor 2004 Gregor JC. Acid suppression and pneumonia: a clinical indication for rational prescribing. JAMA 2004;292(16):2012-3.
89. Howaizi 2003 Howaizi M, Delafosse C. Omeprazole-induced intractable cough. Annals of Pharmacotherapy 2003;37(11):1607-9.
90. Hsu 1994 Hsu JY, Stone RA, Logan-Sinclair RB, Worsdell M, Busst CM, Chung KF. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. European Respiratory Journal 1994;7:1246-53.
91. Ing 1994 Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. American Journal of Respiratory & Critical Care Medicine 1994;149(1):160-7.
92. Irwin 1990 Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. American Review of Respiratory Disease 1990;141:640-7.
93. Irwin 1998 Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, et al.Managing cough as a defence mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998;114(2 Suppl):133S-81S.
94. Irwin 2002a Irwin RS, Madison JM. Diagnosis and treatment of chronic cough due to gastro-esophageal reflux disease and postnasal drip syndrome. Pulmonary Pharmacology & Therapeutics 2002;15(3): 261-6.
95. Irwin 2002b Irwin RS, Zawacki JK, Wilson MM, French CT, Callery MP. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002;121(4):1132-40.
96. Kiljander 2003 Kiljander TO. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough. American Journal of Medicine 2003;115(Suppl 3A):65S-71S.
97. Laheij 2004 Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292(16):1955-60.
98. O'Connell 1994 O'Connell F, Thomas VE, Pride NB, Fuller RW. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. American Journal of Respiratory & Critical Care Medicine 1994;150:374-80.
99. RevMan 2008 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
100. Rudolph 2001 Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al.Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 2001;32(Suppl 2):1S-31S.
101. Rudolph 2003 Rudolph CD. Supraesophageal complications of gastroesophageal reflux in children: challenges in diagnosis and treatment. American Journal of Medicine 2003;115(Suppl 3A):150S-156S.
102. Shay 2004 Shay S, Tutuian R, Sifrim D, Vela M, Wise J, Balaji N, et al.Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. American Journal of Gastroenterology 2004;99(6):1037-43.
103. Sinaiko 2001 Sinaiko AR, Daniels SR. The use of short-acting nefedipine in children with hypertension: Another example of the need for comprehensive drug testing in children. Journal of Paediatrics 2001;139:7-9.
104. Vakil 2006 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. American Journal of Gastroenterology 2006;101(8):1900-20.
105. Vandenplas 1993 Vandenplas Y, Ashkenazi A, Belli D, Boige N, Bouquet J, Cadranel S, et al.A proposition for the diagnosis and treatment of gastrooesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. European Journal of Pediatrics 1993;152:704-11.
106. Yang 2006 Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296(Dec):2947-53.
107. Zerbib 2002 Zerbib F, Guisset O, Lamouliatte H, Quinton A, Galmiche JP, Tunon-de-Lara JM. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. American Journal of Respiratory & Critical Care Medicine 2002;166(9):1206-11.